Topic

Aetna (CVS Health)

A collection of 1134 issues

Do You Qualify for Emflaza (Deflazacort) Coverage by Aetna (CVS Health) in California? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Approval Quick qualification check: Emflaza (deflazacort) coverage by Aetna (CVS Health) in California requires: (1) confirmed Duchenne muscular dystrophy diagnosis with genetic testing, (2) age ≥2 years, (3) documented trial and failure/intolerance of prednisone or prednisolone, and (4) prescribing by a neuromuscular specialist.
6 min read

How to Get Hetlioz (Tasimelteon) Covered by Aetna (CVS Health) in Pennsylvania: Complete Guide with Appeals Process and Forms

Answer Box: Getting Hetlioz (Tasimelteon) Covered by Aetna (CVS Health) in Pennsylvania Fastest Path to Approval: 1) Have your sleep specialist document Non-24-Hour Sleep-Wake Disorder or Smith-Magenis syndrome with sleep logs/actigraphy, 2) Submit prior authorization through Aetna's provider portal with documented melatonin trial failure, 3) If denied,
5 min read

How to Get Aldurazyme (laronidase) Covered by Aetna (CVS Health) in Pennsylvania: Prior Authorization, Appeals, and Cost Assistance Guide

Answer Box: Getting Aldurazyme (laronidase) Covered by Aetna (CVS Health) in Pennsylvania Fastest path to approval: Submit prior authorization through CVS Specialty Pharmacy with genetic confirmation of MPS I, enzyme assay results, and specialist attestation. If denied, you have 180 days for internal appeals, then 4 months for Pennsylvania'
5 min read

How to Get Juxtapid (lomitapide) Covered by Aetna (CVS Health) in Virginia: Prior Authorization Forms, Appeal Timeline & REMS Requirements

Quick Answer: Fastest Path to Approval Getting Juxtapid (lomitapide) covered by Aetna (CVS Health) in Virginia requires three critical steps: 1) Confirm homozygous familial hypercholesterolemia (HoFH) diagnosis with genetic testing or clinical criteria, 2) Document failure of high-intensity statin + ezetimibe + PCSK9 inhibitor therapy with LDL-C still ≥100 mg/dL, and
6 min read

Renewing Opdivo (Nivolumab) Coverage with Aetna (CVS Health) in Virginia: Complete Documentation Guide and Appeal Timeline

Answer Box: Opdivo (Nivolumab) Renewal with Aetna (CVS Health) in Virginia Aetna (CVS Health) requires prior authorization renewal for Opdivo (nivolumab) every 6 months. Submit renewal requests at least 14 days before your current authorization expires via the Availity portal using Novologix. Required documentation includes recent imaging showing no disease
5 min read

How to Get Carbaglu (Carglumic Acid) Covered by Aetna CVS Health in Washington: Complete PA Guide with Appeals Process

Answer Box: Getting Carbaglu (Carglumic Acid) Covered by Aetna CVS Health in Washington Fastest path to approval: Submit prior authorization with confirmed NAGS deficiency diagnosis (genetic/enzyme testing) plus baseline elevated ammonia levels. Aetna requires 12-month PA for all FDA-approved indications. If denied, file internal appeal within 180 days, then
6 min read